Barclays »

Cellectar Biosciences shares owned by Barclays

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6k 561 2.78

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Cellectar Biosciences

Caligan Partners
Stempoint Capital
Vanguard Capital Management
Silverarc Capital Management
Bleichroeder
Jupiter Topco
Balyasny Asset Management
Nantahala Capital Management
Empery Asset Management
Diadema Partners
Stonepine Capital Management
Persistent Asset Partners
Boothbay Fund Management
Geode Capital Management
Vanguard Fiduciary Trust

View all funds holding Cellectar Biosciences